Pharmacogenetics and nutritional supplementation in age-related macular degeneration

Clinical Ophthalmology

Volumn 9, Issue , 2015, Pages 873-876

  Hampton, Blake M ^a   Kovach, Jaclyn L ^a   Schwartz, Stephen G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Age Related Eye Disease Study (AREDS); Age related macular degeneration; Age related maculopathy susceptibility 2 (ARMS2); Complement factor H (CFH); Pharmacogenetics; Randomized clinical trial (RCT)

Indexed keywords

ANTIOXIDANT; COMPLEMENT FACTOR H; ZINC;

AGE RELATED MACULAR DEGENERATION; ARMS2 GENE; ARTICLE; CFH GENE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DISEASE COURSE; GENE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; PHARMACOGENETICS; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; RISK REDUCTION; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

EID: 84929577020     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S84155     Document Type: Article

References (18)

1. Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844–851.
2. Friedman DS, O’Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122(4):564–572.
3. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–1436.
4. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–2015.
5. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150–1155.
6. Schwartz SG, Brantley MA Jr. Pharmacogenetics and age-related macular degeneration. J Ophthalmol. 2011;2011:25249.
7. Hagstrom SA, Ying GS, Pauer GJ, et al. Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology. 2013;120(3):593–599.
8. Lotery AJ, Gibson J, Cree AJ, et al. Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN study. Ophthalmology. 2013;120(12):2637–2643.
9. Klein ML, Francis PJ, Rosner B, et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology. 2008;115(6):1019–1025.
10. Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology. 2013; 120(11):2317–2323.
11. Chew EY, Klein ML, Clemons TE, et al. No Clinically Significant Association between CFH and ARMS2 Genotypes and Response to Nutritional Supplements: AREDS Report Number 38. Ophthalmology. 2014;121(11):2173–2180.
12. Awh CC, Hawken S, Zanke BW. Treatment Response to Antioxidants and Zinc Based on CFH and ARMS2 Genetic Risk Allele Number in the Age-Related Eye Disease Study. Ophthalmology. 2015;122(1):162–169.
13. Chew EY, Klein ML, Clemons TE, Agron E, Abecasis GR. Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test? Ophthalmology. 2015; 122(1):212–215.
14. Stone EM. Genetic testing for age-related macular degeneration: not indicated now. JAMA Ophthalmol. Epub 2015 Mar 19.
15. Grob S, Luo J, Hughes G, et al. Genetic analysis of simultaneous geographic atrophy and choroidal neovascularization. Eye (Lond). 2012; 26(8):1106–1113.
16. Schwartz SG. Re Awh et al.: CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration (Ophthalmology 2013;120:2317–23). Ophthalmology. 2014;121(8):e38.
17. Wittes J, Musch DC. Should we test for genotype in deciding on Age-Related Eye Disease Study supplementation? Ophthalmology. 2015;122(1):3–5.
18. Stone EM, Aldave AJ, Drack AV, et al. Recommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testing. Ophthalmology. 2012;119(11):2408–2410.